Mercier Johanna — SEC Form 4 filings
SEC reporting owner CIK 1782135. 42 Form 4 filings on record with FilingPulse; latest filed 2026-09-16.
Transaction summary — filings shown
Covers all 42 filings on record, filed 2024-01-10 to 2026-09-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 41 legs across 22 filings — 258,602 shares, $30,622,106 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 82.
- Largest priced transaction: sale of 25,524 shares @ $125.83 ($3,211,560) in GILEAD SCIENCES, INC., filed 2025-11-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | Chief Comm & Corp Aff Officer | 37 | — | 41 legs · 258,602 sh · $30,622,106 | 72 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | Director | 5 | — | — | 10 |
Form 4 filings — Mercier Johanna
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-16 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 1,600 @ $143.69 · Sale (S): 800 @ $144.46 · Sale (S): 600 @ $145.29 | EDGAR |
| 2026-09-11 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 2,797 · Tax withholding (F): 1,347 @ $144.81 · Option exercise (M): 2,797 (derivative) | EDGAR |
| 2026-08-18 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 23,110 @ $66.64 · Option exercise (M): 1,890 @ $72.34 · Sale (S): 16,530 @ $137.37 · Sale (S): 11,470 @ $138.04 · Option exercise (M): 23,110 (derivative) @ $0 · Option exercise (M): 1,890 (derivative) @ $0 | EDGAR |
| 2026-07-16 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 3,000 @ $129.92 | EDGAR |
| 2026-06-16 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 1,480 @ $123.42 · Sale (S): 1,070 @ $124.00 · Sale (S): 450 @ $125.40 | EDGAR |
| 2026-06-11 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 2,796 · Tax withholding (F): 1,341 @ $121.48 · Option exercise (M): 2,796 (derivative) | EDGAR |
| 2026-05-29 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/award (A): 2,567 (derivative) @ $0 | EDGAR |
| 2026-05-21 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 3,318 @ $0 · Option exercise (M): 3,318 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 25,000 @ $66.64 · Sale (S): 7,749 @ $130.29 · Sale (S): 11,177 @ $131.19 · Sale (S): 8,374 @ $132.23 · Sale (S): 700 @ $132.75 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2026-04-16 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 3,000 @ $140.96 | EDGAR |
| 2026-03-17 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 3,000 @ $144.23 | EDGAR |
| 2026-03-12 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 6,617 · Tax withholding (F): 3,216 @ $148.56 · Option exercise (M): 6,617 (derivative) · Grant/award (A): 9,590 (derivative) · Grant/award (A): 35,880 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | GILEAD SCIENCES, INC. (GILD) | Grant/award (A): 11,090 @ $0 | EDGAR |
| 2026-02-18 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 25,000 @ $66.64 · Sale (S): 18,405 @ $154.18 · Sale (S): 9,395 @ $154.91 · Sale (S): 200 @ $155.62 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2026-02-05 | 4 | GILEAD SCIENCES, INC. (GILD) | Grant/award (A): 44,867 @ $0 · Tax withholding (F): 24,800 @ $143.28 | EDGAR |
| 2026-01-16 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 3,000 @ $124.31 | EDGAR |
| 2025-12-16 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 3,000 @ $122 | EDGAR |
| 2025-12-11 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 3,842 · Tax withholding (F): 1,814 @ $121.34 · Option exercise (M): 3,842 (derivative) | EDGAR |
| 2025-11-18 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 25,000 @ $66.64 · Sale (S): 25,524 @ $125.83 · Sale (S): 2,476 @ $126.26 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2025-10-16 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 3,000 @ $118.08 | EDGAR |
| 2025-09-16 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 3,000 @ $113.57 | EDGAR |
| 2025-09-11 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 3,844 · Tax withholding (F): 1,819 @ $115.25 · Option exercise (M): 3,844 (derivative) | EDGAR |
| 2025-08-18 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 11,800 @ $66.64 · Sale (S): 11,800 @ $118.50 · Option exercise (M): 700 @ $66.64 · Sale (S): 700 @ $118.97 · Option exercise (M): 11,800 @ $66.64 · Sale (S): 11,800 @ $118.51 · +8 more | EDGAR |
| 2025-07-16 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 3,000 @ $111.03 | EDGAR |
| 2025-06-17 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 3,000 @ $110.17 | EDGAR |
| 2025-06-11 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 3,843 · Tax withholding (F): 1,827 @ $110.09 · Option exercise (M): 3,843 (derivative) | EDGAR |
| 2025-05-23 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 12,500 @ $66.64 · Sale (S): 12,500 @ $107.52 · Option exercise (M): 12,500 @ $66.64 · Sale (S): 12,500 @ $107.52 · Sale (S): 3,000 @ $107.52 · Option exercise (M): 12,500 (derivative) @ $0 · +1 more | EDGAR |
| 2025-05-22 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 1,435 @ $0 · Grant/award (A): 3,318 (derivative) @ $0 · Option exercise (M): 1,435 (derivative) @ $0 | EDGAR |
| 2025-03-12 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 8,080 · Tax withholding (F): 3,907 @ $117.21 · Option exercise (M): 8,080 (derivative) · Grant/award (A): 49,020 (derivative) @ $0 · Grant/award (A): 11,090 (derivative) | EDGAR |
| 2025-02-06 | 4 | GILEAD SCIENCES, INC. (GILD) | Grant/award (A): 19,793 @ $0 · Grant/award (A): 70,712 @ $0 · Tax withholding (F): 45,666 @ $97.99 | EDGAR |
| 2024-12-11 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 3,752 · Tax withholding (F): 1,739 @ $92.34 · Option exercise (M): 3,752 (derivative) | EDGAR |
| 2024-11-07 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 5,000 @ $91.28 | EDGAR |
| 2024-09-13 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 15,925 @ $84.23 · Sale (S): 13,432 @ $83.25 | EDGAR |
| 2024-09-11 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 3,752 · Tax withholding (F): 1,734 @ $81.44 · Option exercise (M): 3,752 (derivative) | EDGAR |
| 2024-08-29 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 9,513 @ $78.03 | EDGAR |
| 2024-08-14 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 5,490 @ $73.98 | EDGAR |
| 2024-06-11 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 3,751 · Tax withholding (F): 1,714 @ $65.25 · Option exercise (M): 3,751 (derivative) | EDGAR |
| 2024-05-23 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/award (A): 1,435 (derivative) @ $0 · Grant/award (A): 2,982 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 2,100 @ $0 · Option exercise (M): 2,100 (derivative) @ $0 | EDGAR |
| 2024-03-11 | 4 | GILEAD SCIENCES, INC. (GILD) | Option exercise (M): 3,025 · Option exercise (M): 6,819 · Tax withholding (F): 4,559 @ $75.12 · Option exercise (M): 3,025 (derivative) · Option exercise (M): 6,819 (derivative) · Grant/award (A): 87,970 (derivative) @ $0 · +1 more | EDGAR |
| 2024-02-02 | 4 | GILEAD SCIENCES, INC. (GILD) | Grant/award (A): 20,086 @ $0 · Grant/award (A): 53,969 @ $0 · Tax withholding (F): 22,509 @ $78.26 | EDGAR |
| 2024-01-10 | 4 | GILEAD SCIENCES, INC. (GILD) | Sale (S): 8,242 @ $85.23 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-10 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1782135 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →